Evolent program achieves 20% reduction in use of low-value oncology regimens
Go back to Evolent program achieves 20% reduction in use of low-value oncology regimens| (NYSE: EVH) | Delayed: 3.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.96 | 52 Week High | $26.84 | |||
| Open | $3.96 | 52 Week Low | $8.14 | |||
| Day High | $3.96 | P/E | N/A | |||
| Day Low | $3.96 | EPS | $0.00 | |||
| Volume | 93 | |||||



